Interventional Cardiology Devices | Market Insights | Canada | 2022
The Canadian IC device market is a uniquely challenging space characterized by eroding ASPs, an aging population, and an increasing prevalence of complex lesions requiring use of niche devices, such as intravascular imaging catheters and CTO devices. Moreover, the COVID-19 global pandemic will result in lost procedure volumes in the short term. However, the market will be supported by the emergence of specialized premium-priced technologies to diagnose and treat complex CADs.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for IC devices in Canada, with market projections across an 11-year period.
